OB_1170x120_9-14-20

Joseph Ciaffoni

Endo makes changes to executive team

Endo makes changes to executive team

DUBLIN, Ireland — Endo International plc has announced executive changes in its U.S. branded drug and research-and-development units. Endo said Patrick Barry has been appointed as senior vice president of U.S. branded pharmaceuticals effective immediately and Matthew Davis as senior vice president of R&D for branded pharmaceuticals effective Jan. 3. Barry, who comes to Endo

Endo tabs Ciaffoni as U.S branded Rx president

Endo tabs Ciaffoni as U.S branded Rx president

DUBLIN, Ireland — Joseph Ciaffoni has been named president of U.S. branded pharmaceuticals at Endo International plc. Endo said Ciaffoni is slated to start in the new post on Aug. 15. He joins the company from Biogen, where he was senior vice president of the global specialty medicines group. “I am thrilled to be joining